Kstation
SYNERFILL Face (260mg × 1 Vial)
8200
$82.00
Unit price perFormulation
Key ingredients
- 01 Poly-L-Lactic Acid (PLLA)200 mg/vialBiostimulator · neocollagenesis; microporous spheres; facial volume & lift
- 02 Hyaluronic Acid60 mg/vialImmediate volumization & hydration · dual-MW (H-HA/L-HA) carrier, CMC & Mannitol free
Product Identification
SYNERFILL Face
Hybrid HA-PLLA Collagen Stimulator
Monica Lyophilized Powder 260mg Vial
Total Volume/Content
260mg × 1 Vial
Formulation Type
Lyophilized powder (Requires reconstitution prior to injection)
Core Ingredients & Technology
Active Ingredients (260mg)
- PLLA (Poly-L-lactic acid): 200mg. Acts as a bio-stimulator triggering fibroblast activity for long-lasting neocollagenesis.
- H-HA (High-molecular-weight HA): 30mg.
- L-HA (Low-molecular-weight HA): 30mg. Provides immediate hydration and acts as a carrier/suspension agent for PLLA.
Key Technical Features
Microporous Sphere Technology: Utilizes spherical PLLA particles with internal pores, maximizing the surface area for higher collagen/elastin production and allowing for smoother, less painful injections. CMC & Mannitol Free: Uses HA instead for suspension, adding hydration benefits.
PLLA + HA Hybrid Microporous Spheres CMC & Mannitol Free
Efficacy & Benefits
Main Effects
- Dual Volumization: Immediate volumizing effect from HA, followed by sustained neocollagenesis from PLLA.
- Collagenesis: Active stimulation and generation of collagen and elastin under the skin.
- Wrinkle Reduction: Effectively reduces fine lines and deep wrinkles.
- Skin Improvement: Enhances skin hydration, elasticity, compliance, and smooths overall texture.
Recommended Areas
Nasolabial folds, Temple, Cheek, Jowls, Eye area, Chin, Jawline, Marionette lines, Forehead, and Neck.
Usage Protocol
Application Method
Subcutaneous injection into the subcutaneous fat layer using a thin needle or cannula.
Reconstitution Instructions Dilute the 260mg vial to create 9mL of suspension solutionMix with 7mL of sterile saline and 2mL of 2% Lidocaine. Must be completely and evenly reconstituted before use.
Treatment Cycle & Duration
Standard Cycle: 2 to 3 sessions at 1-month intervals.
Duration: Long-lasting PLLA effects maintained for up to 24 months.
SYNERFILL Series
| Product | Target Area & Focus |
|---|---|
| SYNERFILL Face (260mg) | Optimized for facial volume restoration, fine wrinkles, and lifting. |
| SYNERFILL Body | Tailored for larger body areas requiring extensive volume (hips, buttocks, abdomen). |
Storage & Handling
Storage Conditions
Room temperature (1–30°C). Do not freeze.
Shelf Life
Typically 24–36 months from the manufacturing date (Unopened).
Safety Information
Contraindications Pregnancy, breastfeeding, patients with active skin inflammation/infection at the injection site, or a history of keloid formation/hypertrophic scarring.
Safety Warnings Professional medical use only. Must strictly avoid intravascular injection to prevent vascular occlusion or necrosis.
Crucial Post-Treatment Care
To prevent the formation of subcutaneous nodules (granulomas), practitioners strictly recommend the "5-5-5 Rule" for patients: Massage the treated area for 5 minutes, 5 times a day, for 5 days post-treatment to ensure even particle distribution.
Keywords
SYNERFILL Face PLLA Filler Poly-L-lactic acid Collagen Stimulator Hybrid HA PLLA Neocollagenesis Liquid Facelift Microporous Sphere Skin Booster Monica
